This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Liraglutide (LRT) ELISA Kit-Competitive
Product Overview
BioVenic General Liraglutide (LRT) ELISA Kit-Competitive is designed for the quantitative determination of General Liraglutide (LRT) in serum, plasma, tissue homogenate, cell culture supernatant, cell extract, and other biological fluids using a Competitive ELISA method. For research use only.
Specifications
Target Information
Liraglutide is an anti-diabetic medication used to treat type 2 diabetes mellitus and prevent cardiovascular complications associated with diabetes. It is also prescribed for chronic obesity. As a GLP-1 analog, it helps regulate blood sugar levels and may aid in weight management. In veterinary medicine, it is sometimes prescribed to manage diabetes in cats and dogs. However, its use and dosage should always be determined by a veterinarian based on the specific needs of the animal.
Shipping and Storage
This product is shipped with gel ice packs. It is recommended to store at 2-8 °C (Up to 6 months).
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
References
- Knudsen, L. B. & Lau, J. The Discovery and Development of Liraglutide and Semaglutide. Frontiers in endocrinology. 2019, 10.